IFITM3 affects the level of antibody response after influenza vaccination

Interferon-induced transmembrane protein 3 (IFITM3) as an antiviral factor can inhibit replication of several viruses including influenza virus. A single-nucleotide polymorphism rs12252-C of IFITM3 results in a truncated IFITM3 protein lacking its first 21 amino acids, which is much higher in the Ha...

Full description

Saved in:
Bibliographic Details
Main Authors: Na Lei, Yan Li, Qiang Sun, Jian Lu, Jianfang Zhou, Zi Li, Liqi Liu, Junfeng Guo, Kun Qin, Haibin Wang, Jianhong Zhao, Chong Li, Lingli Sun, Dayan Wang, Zhendong Zhao, Yuelong Shu
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Emerging Microbes and Infections
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/22221751.2020.1756696
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850203284367736832
author Na Lei
Yan Li
Qiang Sun
Jian Lu
Jianfang Zhou
Zi Li
Liqi Liu
Junfeng Guo
Kun Qin
Haibin Wang
Jianhong Zhao
Chong Li
Lingli Sun
Dayan Wang
Zhendong Zhao
Yuelong Shu
author_facet Na Lei
Yan Li
Qiang Sun
Jian Lu
Jianfang Zhou
Zi Li
Liqi Liu
Junfeng Guo
Kun Qin
Haibin Wang
Jianhong Zhao
Chong Li
Lingli Sun
Dayan Wang
Zhendong Zhao
Yuelong Shu
author_sort Na Lei
collection DOAJ
description Interferon-induced transmembrane protein 3 (IFITM3) as an antiviral factor can inhibit replication of several viruses including influenza virus. A single-nucleotide polymorphism rs12252-C of IFITM3 results in a truncated IFITM3 protein lacking its first 21 amino acids, which is much higher in the Han Chinese population and associated with severe illness in adults infected with pandemic influenza H1N1/09 virus. To investigate if IFITM3 or IFITM3 rs12252-C could affect the antibody response after influenza vaccination, we detected the haemagglutination inhibition (HI) of 171 healthy young adult volunteers (IFITM3 rs12252-C/C, C/T, T/T carriers) and in an IFITM3-deletion mouse model (Ifitm3-/-) after trivalent inactivated vaccine (TIV) immunization. Seroconversion rates for H1N1, H3N2 and B viruses in IFITM3 rs12252-C/C genotype carriers was lower compared with C/T and T/T donors. Significantly lower levels of specific antibodies to H1N1, H3N2 and B viruses and total IgG were observed in Ifitm3-/- mice. Correspondingly, the numbers of splenic germinal centre (GC) B cells, plasma cells, TIV-specific IgG+ antibody secreting cells and T follicular helper cells in Ifitm3-/- mice were lower compared with wild type mice. However, the number of memory B cells was higher in Ifitm3-/- mice at day 7 after booster. The HI level of Ifitm3-/- mice remained lower than WT mice after third vaccination. Moreover, the transcriptional network regulating GC B cell and plasma cell differentiation was abnormal in Ifitm3-/- mice. Our results indicate that IFITM3 deletion attenuated the antibody response. The mechanism of influenza-IFITM3 interactions affecting the antibody response requires further investigation.
format Article
id doaj-art-0f6ca8302b06402eae67002cfd7eac62
institution OA Journals
issn 2222-1751
language English
publishDate 2020-01-01
publisher Taylor & Francis Group
record_format Article
series Emerging Microbes and Infections
spelling doaj-art-0f6ca8302b06402eae67002cfd7eac622025-08-20T02:11:34ZengTaylor & Francis GroupEmerging Microbes and Infections2222-17512020-01-019197698710.1080/22221751.2020.1756696IFITM3 affects the level of antibody response after influenza vaccinationNa Lei0Yan Li1Qiang Sun2Jian Lu3Jianfang Zhou4Zi Li5Liqi Liu6Junfeng Guo7Kun Qin8Haibin Wang9Jianhong Zhao10Chong Li11Lingli Sun12Dayan Wang13Zhendong Zhao14Yuelong Shu15National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Prevention and Control, Beijing, People’s Republic of ChinaNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Prevention and Control, Beijing, People’s Republic of ChinaNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Prevention and Control, Beijing, People’s Republic of ChinaNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Prevention and Control, Beijing, People’s Republic of ChinaNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Prevention and Control, Beijing, People’s Republic of ChinaNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Prevention and Control, Beijing, People’s Republic of ChinaNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Prevention and Control, Beijing, People’s Republic of ChinaNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Prevention and Control, Beijing, People’s Republic of ChinaNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Prevention and Control, Beijing, People’s Republic of ChinaChaoyang District Center for Disease Prevention and Control, Beijing, People’s Republic of ChinaChaoyang District Center for Disease Prevention and Control, Beijing, People’s Republic of ChinaChaoyang District Center for Disease Prevention and Control, Beijing, People’s Republic of ChinaChaoyang District Center for Disease Prevention and Control, Beijing, People’s Republic of ChinaNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Prevention and Control, Beijing, People’s Republic of ChinaNHC Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of ChinaNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Prevention and Control, Beijing, People’s Republic of ChinaInterferon-induced transmembrane protein 3 (IFITM3) as an antiviral factor can inhibit replication of several viruses including influenza virus. A single-nucleotide polymorphism rs12252-C of IFITM3 results in a truncated IFITM3 protein lacking its first 21 amino acids, which is much higher in the Han Chinese population and associated with severe illness in adults infected with pandemic influenza H1N1/09 virus. To investigate if IFITM3 or IFITM3 rs12252-C could affect the antibody response after influenza vaccination, we detected the haemagglutination inhibition (HI) of 171 healthy young adult volunteers (IFITM3 rs12252-C/C, C/T, T/T carriers) and in an IFITM3-deletion mouse model (Ifitm3-/-) after trivalent inactivated vaccine (TIV) immunization. Seroconversion rates for H1N1, H3N2 and B viruses in IFITM3 rs12252-C/C genotype carriers was lower compared with C/T and T/T donors. Significantly lower levels of specific antibodies to H1N1, H3N2 and B viruses and total IgG were observed in Ifitm3-/- mice. Correspondingly, the numbers of splenic germinal centre (GC) B cells, plasma cells, TIV-specific IgG+ antibody secreting cells and T follicular helper cells in Ifitm3-/- mice were lower compared with wild type mice. However, the number of memory B cells was higher in Ifitm3-/- mice at day 7 after booster. The HI level of Ifitm3-/- mice remained lower than WT mice after third vaccination. Moreover, the transcriptional network regulating GC B cell and plasma cell differentiation was abnormal in Ifitm3-/- mice. Our results indicate that IFITM3 deletion attenuated the antibody response. The mechanism of influenza-IFITM3 interactions affecting the antibody response requires further investigation.https://www.tandfonline.com/doi/10.1080/22221751.2020.1756696Interferon-induced transmembrane protein 3IFITM3SNP rs12252influenza virustrivalent inactivated vaccineimmune response
spellingShingle Na Lei
Yan Li
Qiang Sun
Jian Lu
Jianfang Zhou
Zi Li
Liqi Liu
Junfeng Guo
Kun Qin
Haibin Wang
Jianhong Zhao
Chong Li
Lingli Sun
Dayan Wang
Zhendong Zhao
Yuelong Shu
IFITM3 affects the level of antibody response after influenza vaccination
Emerging Microbes and Infections
Interferon-induced transmembrane protein 3
IFITM3
SNP rs12252
influenza virus
trivalent inactivated vaccine
immune response
title IFITM3 affects the level of antibody response after influenza vaccination
title_full IFITM3 affects the level of antibody response after influenza vaccination
title_fullStr IFITM3 affects the level of antibody response after influenza vaccination
title_full_unstemmed IFITM3 affects the level of antibody response after influenza vaccination
title_short IFITM3 affects the level of antibody response after influenza vaccination
title_sort ifitm3 affects the level of antibody response after influenza vaccination
topic Interferon-induced transmembrane protein 3
IFITM3
SNP rs12252
influenza virus
trivalent inactivated vaccine
immune response
url https://www.tandfonline.com/doi/10.1080/22221751.2020.1756696
work_keys_str_mv AT nalei ifitm3affectsthelevelofantibodyresponseafterinfluenzavaccination
AT yanli ifitm3affectsthelevelofantibodyresponseafterinfluenzavaccination
AT qiangsun ifitm3affectsthelevelofantibodyresponseafterinfluenzavaccination
AT jianlu ifitm3affectsthelevelofantibodyresponseafterinfluenzavaccination
AT jianfangzhou ifitm3affectsthelevelofantibodyresponseafterinfluenzavaccination
AT zili ifitm3affectsthelevelofantibodyresponseafterinfluenzavaccination
AT liqiliu ifitm3affectsthelevelofantibodyresponseafterinfluenzavaccination
AT junfengguo ifitm3affectsthelevelofantibodyresponseafterinfluenzavaccination
AT kunqin ifitm3affectsthelevelofantibodyresponseafterinfluenzavaccination
AT haibinwang ifitm3affectsthelevelofantibodyresponseafterinfluenzavaccination
AT jianhongzhao ifitm3affectsthelevelofantibodyresponseafterinfluenzavaccination
AT chongli ifitm3affectsthelevelofantibodyresponseafterinfluenzavaccination
AT linglisun ifitm3affectsthelevelofantibodyresponseafterinfluenzavaccination
AT dayanwang ifitm3affectsthelevelofantibodyresponseafterinfluenzavaccination
AT zhendongzhao ifitm3affectsthelevelofantibodyresponseafterinfluenzavaccination
AT yuelongshu ifitm3affectsthelevelofantibodyresponseafterinfluenzavaccination